BioNTech and Pfizer Highlight Bispecifics Progress at ASCO, Rick Pazdur Offers Optimism
At the ASCO event, BioNTech and Pfizer shared encouraging developments in lung cancer treatments, while Rick Pazdur expressed optimism regarding FDA perspectives.